3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Biphenotypic, Acute
3
Lymphoma, Mantle-Cell
2
Leukemia, Myeloid, Accelerated Phase
2
Down Syndrome
2
Blast Crisis
2
Renal Pelvis and Ureter Urothelial Carcinoma
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Radiotherapy
2
Pemetrexed
2
toripalimab
1
sintilimab
1
pertuzumab
1
azeliragon
1
Trastuzumab
1
Spinal Puncture
1
Specimen Handling
1
Magnetic Resonance Spectroscopy
1
Immune Checkpoint Inhibitors
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningeal Carcinomatosis
×
merphos
×
30 days
×
Clear all
No trials found.